[go: up one dir, main page]

AU2001243248A1 - Method for the prevention or reduction of vascular access dysfunction - Google Patents

Method for the prevention or reduction of vascular access dysfunction

Info

Publication number
AU2001243248A1
AU2001243248A1 AU2001243248A AU4324801A AU2001243248A1 AU 2001243248 A1 AU2001243248 A1 AU 2001243248A1 AU 2001243248 A AU2001243248 A AU 2001243248A AU 4324801 A AU4324801 A AU 4324801A AU 2001243248 A1 AU2001243248 A1 AU 2001243248A1
Authority
AU
Australia
Prior art keywords
prevention
reduction
vascular access
access dysfunction
dysfunction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001243248A
Inventor
Theodore M. Danoff
Diane K. Jorkasky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU2001243248A1 publication Critical patent/AU2001243248A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001243248A 2000-02-23 2001-02-22 Method for the prevention or reduction of vascular access dysfunction Abandoned AU2001243248A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US18425900P 2000-02-23 2000-02-23
US60184259 2000-02-23
US26286101P 2001-01-19 2001-01-19
US60262861 2001-01-19
US26829301P 2001-02-13 2001-02-13
US60268293 2001-02-13
US26898601P 2001-02-15 2001-02-15
US60268986 2001-02-15
PCT/US2001/005846 WO2001062241A1 (en) 2000-02-23 2001-02-22 Method for the prevention or reduction of vascular access dysfunction

Publications (1)

Publication Number Publication Date
AU2001243248A1 true AU2001243248A1 (en) 2001-09-03

Family

ID=27497602

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001243248A Abandoned AU2001243248A1 (en) 2000-02-23 2001-02-22 Method for the prevention or reduction of vascular access dysfunction

Country Status (2)

Country Link
AU (1) AU2001243248A1 (en)
WO (1) WO2001062241A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1601379A1 (en) * 2003-02-13 2005-12-07 Licentia OY Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of a patient subjected to thrombolyses
CA2589871A1 (en) * 2004-12-08 2006-06-15 Pervasis Therapeutics, Inc. Materials and methods for treating and managing plaque disease
WO2006062909A2 (en) * 2004-12-08 2006-06-15 Pervasis Therapeutics, Inc. Methods and compositions for enhancing vascular access
AU2006238892B2 (en) 2005-04-21 2011-01-27 Massachusetts Institute Of Technology Materials and methods for altering an immune response to exogenous and endogenous immunogens, including syngeneic and non-syngeneic cells, tissues or organs
WO2007001744A2 (en) 2005-06-21 2007-01-04 Pervasis Therapeutics, Inc. Methods and compositions for enhancing vascular access
CN104751440A (en) * 2013-12-31 2015-07-01 西门子医疗保健诊断公司 Method and device based on image processing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2617407B2 (en) * 1992-09-14 1997-06-04 キッセイ薬品工業株式会社 Preventive and therapeutic agent for intimal cell hyperproliferative disease
US6019104A (en) * 1996-12-30 2000-02-01 Kissei Pharmaceutical Co., Ltd. Method for the treatment or prevention of restenosis associated with coronary intervention

Also Published As

Publication number Publication date
WO2001062241A1 (en) 2001-08-30

Similar Documents

Publication Publication Date Title
PL364995A1 (en) Method for the treatment or prevention of flavivirus
GB9912842D0 (en) Process for reducing the acidity of oil
AU7373700A (en) Vascular closure
AU2001240115A1 (en) Method for the preparation of tetrahydrobenzothiepines
AU6674100A (en) Manhole or catch basin assembly
HUP0104302A3 (en) Inhibition of the formation of vascular hyperpermeability
AU2001245977A1 (en) Method and composition for preventing or reducing the symptoms of menopause
AU2001250821A1 (en) Methods and compositions for the treatment and prevention of erectile dysfunction
AU2002225894A1 (en) Methods and compositions for the control of coccidiosis
AU7902400A (en) Method for the preparation of 5-carboxyphthalide
AU4136901A (en) Novel methods for the treatment and prevention of dizziness and pruritus
AU2001259817A1 (en) Methods of and compounds for inhibiting calpains
AU2001290710A1 (en) Method for increasing the effectiveness of antiinfective agents
AU2001287668A1 (en) Method for the sterilisation of objects
AU2001261676A1 (en) Method and reagent for the inhibition of erg
AUPQ629000A0 (en) Inhibition of fungi
AU2001264522A1 (en) Methods and compositions for the prevention of myopia
AU2001243248A1 (en) Method for the prevention or reduction of vascular access dysfunction
AU2728901A (en) Method of making hydrofluorocarbons
AU2002216930A1 (en) System for treating vascular adhesions
MXPA03003346A (en) Method of purifying pravastatin or its pharmacologically acceptable salt.
AU2001243297A1 (en) Method for treating or preventing depression
AU1130901A (en) Method for the preparation of 5-carboxyphthalide
AU2001276049A1 (en) Method of enabling the spacing of metal units
AU2002256967A1 (en) Treating or reducing the risk of cardiovascular disease